New Clinical Data with 1,563 Patients

Video Player is loading.
Current Time 0:00
Duration 2:41
Loaded: 0%
Stream Type LIVE
Remaining Time 2:41
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected
    • en (Main), selected

      Dr. Dubiner and Noecker received financial compensation for the recording of this video.

      TRAVATAN Z® (travoprost ophthalmic solution) 0.004%

      INDICATIONS AND USAGE

      TRAVATAN Z® Solution is a prostaglandin analog indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.

      Dosage and Administration:

      One drop in the affected eye(s) once daily in the evening.

      IMPORTANT SAFETY INFORMATION

      Warnings and Precautions:

      Pigmentation: Pigmentation of the iris, periorbital tissue (eyelid) and eyelashes can occur. Iris pigmentation likely to be permanent.

      Eyelash Changes: Gradual change to eyelashes including increased length, thickness and number of lashes. Usually reversible.

      Adverse Reactions:

      Most common adverse reaction (30% to 50%) is conjunctival hyperemia.

      Use in Specific Populations:

      Use in pediatric patients below the age of 16 years is not recommended because of potential safety concerns related to increased pigmentation following long-term chronic use.

      For additional information about TRAVATAN Z® Solution, please refer to the full prescribing information.